[Improvement of tissue fibrosis in TAFRO syndrome by prednisolone monotherapy]

Rinsho Ketsueki. 2024;65(4):237-242. doi: 10.11406/rinketsu.65.237.
[Article in Japanese]

Abstract

We report the case of a 48-year-old man who presented with fatigue and weight loss. A local physician observed elevated alkaline phosphatase levels, anemia, thrombocytopenia, and renal dysfunction. Fever also appeared, and the patient was admitted to our hospital. Computed tomography revealed hepatosplenomegaly, pleural and ascitic fluid, and left axillary lymphadenopathy. Bone marrow biopsy indicated hyperplasia with increased megakaryocytes and reticulin fibrosis. Axillary lymph node biopsy showed Castleman's disease-like features. Liver biopsy revealed proliferation of reticulin fibrosis. Therefore, TAFRO syndrome was diagnosed and treatment with 1 mg/kg prednisolone was started. Anemia and thrombocytopenia improved, and after 24 weeks of treatment, serum hyaluronic acid and type IV collagen decreased to the normal range. Bone marrow biopsy after 18 weeks of treatment showed decreased reticular fibers. In TAFRO syndrome, improvement of liver and bone marrow fibrosis can be expected with adequate intervention, and serum hyaluronic acid and type IV collagen are useful for evaluating fibrosis.

Keywords: Fibrosis; Hyaluronic acid; TAFRO syndrome; Type IV collagen.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Castleman Disease / drug therapy
  • Castleman Disease / pathology
  • Fibrosis
  • Humans
  • Male
  • Middle Aged
  • Prednisolone* / administration & dosage
  • Syndrome
  • Treatment Outcome

Substances

  • Prednisolone

Supplementary concepts

  • Multi-centric Castleman's Disease